These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 4391435)

  • 1. Dopa-induced excitement in the cat. Its relationship to brain norepinephrine concentrations.
    Reis DJ; Moorhead DT; Merlino N
    Arch Neurol; 1970 Jan; 22(1):31-9. PubMed ID: 4391435
    [No Abstract]   [Full Text] [Related]  

  • 2. The effects of disulfiram on the repletion of brain catecholamine stores.
    Goldstein M; Nakajima K
    Life Sci; 1966 Jun; 5(12):1133-8. PubMed ID: 5963538
    [No Abstract]   [Full Text] [Related]  

  • 3. Behavioral and biochemical effects of L-dopa after peripheral decarboxylase inhibition.
    Butcher LL; Engel J
    Brain Res; 1969 Sep; 15(1):233-42. PubMed ID: 5807767
    [No Abstract]   [Full Text] [Related]  

  • 4. Catecholamines, drugs, and behavior: mutual interactions.
    Seiden LS; Campbell AB
    Adv Biochem Psychopharmacol; 1974; 12(0):325-38. PubMed ID: 4418348
    [No Abstract]   [Full Text] [Related]  

  • 5. Dopa reversal of reserpine enhancement of audiogenic seizure susceptibility in mice.
    Boggan WO; Seiden LS
    Physiol Behav; 1971 Mar; 6(3):215-7. PubMed ID: 5125476
    [No Abstract]   [Full Text] [Related]  

  • 6. Reversal of the reserpine-induced suppression of the conditioned avoidance response in the cat by L-DOPA.
    Seiden LS; Hanson LC
    Psychopharmacologia; 1964 Oct; 6(4):239-44. PubMed ID: 5830803
    [No Abstract]   [Full Text] [Related]  

  • 7. Photic evoked cortical potentials: interaction of reserpine, monoamine oxidase inhibition, and DOPA.
    Sabelli HC; Giardina WJ; Bartizal F
    Biol Psychiatry; 1971; 3(3):273-80. PubMed ID: 5163812
    [No Abstract]   [Full Text] [Related]  

  • 8. VI. Catecholamine metabolism in the brain and adrenal medulla during addiction to morphine and in the early abstinence period.
    Maynert EW
    Res Publ Assoc Res Nerv Ment Dis; 1968; 46():89-95. PubMed ID: 5749391
    [No Abstract]   [Full Text] [Related]  

  • 9. Behavioral, biochemical, and histochemical analyses of the central effects of monoamine precursors after peripheral decarboxylase inhibition.
    Butcher LL; Engel J; Fuxe K
    Brain Res; 1972 Jun; 41(2):387-411. PubMed ID: 4402607
    [No Abstract]   [Full Text] [Related]  

  • 10. The anticonvulsant effect of carbonic anhydrase inhibitors in mice--a noradrenergic mechanism of action.
    Torchiana ML; Lotti VJ; Stone CA
    Eur J Pharmacol; 1973 Mar; 21(3):343-9. PubMed ID: 4145319
    [No Abstract]   [Full Text] [Related]  

  • 11. Emetic effect of biogenic amines.
    Cahen RL
    Res Clin Stud Headache; 1970; 3():227-44. PubMed ID: 4144415
    [No Abstract]   [Full Text] [Related]  

  • 12. The relationship between brain norepinephrine and aggressive behavior.
    Reis DJ
    Res Publ Assoc Res Nerv Ment Dis; 1972; 50():266-97. PubMed ID: 4341950
    [No Abstract]   [Full Text] [Related]  

  • 13. Localization of the site of the central sympatho-inhibitory action of 1-Dopa in dogs and cats.
    Schmitt H; Fenard S
    Eur J Pharmacol; 1973 May; 22(2):212-6. PubMed ID: 4715222
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of L-dopa and inhibitors of decarboxylase and monoamine oxidase on brain noradrenaline levels and blood pressure in spontaneously hypertensive rats.
    Yamori Y; De Jong W; Yamabe H; Lovenberg W; Sjoerdsma A
    J Pharm Pharmacol; 1972 Sep; 24(9):690-5. PubMed ID: 4404071
    [No Abstract]   [Full Text] [Related]  

  • 15. 3,4-Dihydroxyphenylalanine (dopa), dopamine and norepinephrine storage in the rat heart after L-dopa--further evidence for norepinephrine release.
    Landsberg L; Bruno SJ
    Biochem Pharmacol; 1973 Feb; 22(3):417-25. PubMed ID: 4687136
    [No Abstract]   [Full Text] [Related]  

  • 16. An analysis of DOPA-induced locomotor stimulation in mice with inhibited extracerebral decarboxylase.
    Przegaliński E; Kleinrok Z
    Psychopharmacologia; 1972; 23(3):279-88. PubMed ID: 4260342
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of L-DOPA on conditioned avoidance responding after behavioural suppression by alpha-methyltyrosine or reserpine in mice.
    Ahlenius S
    Neuropharmacology; 1974 Aug; 13(8):729-39. PubMed ID: 4444759
    [No Abstract]   [Full Text] [Related]  

  • 18. The respective involvement of noradrenaline and its deaminated metabolites in waking and paradoxical sleep: a neuropharmacological model.
    Jones B
    Brain Res; 1972 Apr; 39(1):121-36. PubMed ID: 4402049
    [No Abstract]   [Full Text] [Related]  

  • 19. The influence of various pharmacological agents on the desynchronization produced by DOPA in the cerveau isolé preparation.
    Kadzielawa K; Widy-Tyszkiewicz E
    Electroencephalogr Clin Neurophysiol; 1970 Mar; 28(3):266-72. PubMed ID: 4190531
    [No Abstract]   [Full Text] [Related]  

  • 20. Blockade of L-dopa reversal of reserpine-induced conditioned avoidance response suppression by disulfiram.
    Seiden LS; Peterson DD
    J Pharmacol Exp Ther; 1968 Sep; 163(1):84-90. PubMed ID: 5673718
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.